Terence R. Flotte, MD
Celia and Isaac Haidak Professor, Dean of the T.H. Chan School of Medicine
Provost and Executive Deputy Chancellor
About the deanTerence R. Flotte, MD, is provost, dean and executive deputy chancellor of UMass Chan Medical School, the only public medical school in Massachusetts. Since joining UMass Chan in 2007, Dr. Flotte has forged a path of unprecedented growth and achievement for the research, education and academic missions of the campus. An internationally known scientist, Flotte has conducted research on cutting edge molecular therapeutics that led to the first successful gene transfer with adeno-associated virus (AAV) in animals and the first ever human trial of an AAV. He also led the first human recombinant AAV trials in alpha-1 antitrypsin deficiency and Tay-Sachs disease, with the latter showing promising clinical benefits. He is the author of more than 280 scholarly papers and his research has been funded by the National Institutes of Health and the Alpha One Foundation. Since 2015, Flotte has also been editor-in-chief of gene therapy’s oldest journal family, Human Gene Therapy. |
-
Read more
-
UMass Chan Medical School visit fosters collaboration with Dubai Health
Read more -
UMass Chan and MITRE launch Health AI Assurance Laboratory with MassTech grant
Read more -
At Second Look Day, presence and intentionality connect students to UMass Chan
Read more -
UMass Chan and Lahey partner on new clinical and quantitative research science hub
Read more -
Match Day 2024 at UMass Chan: ‘Excited about the future . . . and the patients I will serve’
Read more -
Dean Flotte testifies at congressional hearing in support of gene therapy development
Read more -
New issue of @umasschan magazine highlights stories of gene therapy ‘heroes’
Read more -
Top story: Family connects with researchers behind Canavan gene therapy
Read more -
Top story: UMass Chan best in New England for primary care education
Read more